Professor of Medicine, UCSF
Pulmonology
Dr. Talmadge E. King Jr., MD
|
|
Give Review
Talmadge King is an expert in the field of Pulmonology. He graduated from Harvard Medical School. Harvard Medical School is a one of the best medicals schools. Harvard Medical School is ranked 1 in research and 12 in primary care medicine He received awards:"CMS Meaningful Use Stage 1 Certification", "Elected Member" and "Whos Who in Medicine and Healthcare". Talmadge King is a published doctor as well. He has 62 publications published. The latest was: Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials.
Publications
- Smoking-related idiopathic Interstitial pneumonia.
- Idiopathic Pulmonary Fibrosis: CT and Risk of Death.
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis.
- Comprehensive assessment of the long-term safety of pirfenidone in patients with idiopathic pulmonary fibrosis.
- All-cause Mortality Rate in Patients with Idiopathic Pulmonary Fibrosis: Implications for the Design and Execution of Clinical Trials.
- Predictors of mortality in rheumatoid arthritis-related Interstitial lung disease.
- Future Directions in Idiopathic Pulmonary Fibrosis Research: An NHLBI Workshop Report.
- Rheumatoid Arthritis-associated Interstitial Lung Disease: Radiologic Identification of Usual Interstitial Pneumonia Pattern.
- Prevalence and clinical significance of circulating autoantibodies in idiopathic pulmonary fibrosis.
- A multidimensional index and staging system for idiopathic pulmonary fibrosis.
- Gastroesophageal Reflux Therapy is Associated with Longer Survival in Idiopathic Pulmonary Fibrosis.
- Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis: Test Properties and Minimal Clinically Important Difference.
- Ascertainment of Individual Risk of Mortality for Patients with Idiopathic Pulmonary Fibrosis.
- BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis.
- Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference.
- Smoking and subclinical Interstitial lung disease.
- Clinical course and prediction of survival in idiopathic pulmonary fibrosis.
- Workshop on idiopathic pulmonary fibrosis in older adults.
- Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis.
- Low prevalence of chronic beryllium Disease among workers at a nuclear weapons research and development facility.
- Undifferentiated connective tissue disease-associated Interstitial lung disease: changes in lung function.
- Does chronic microaspiration cause idiopathic pulmonary fibrosis?
- Clinical decisions. American Board of Internal Medicine maintenance of certification program.
- Rheumatoid arthritis-associated Interstitial lung disease: the relevance of histopathologic and radiographic pattern.
- Multisociety task force recommendations of competencies in Pulmonary and Critical Care Medicine.
- Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis.
- Idiopathic nonspecific Interstitial pneumonia: report of an American Thoracic Society project.
- Prognostic significance of bronchoalveolar lavage cellular analysis in scleroderma Lung disease.
- BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis.
- Baseline BAL neutrophilia predicts early mortality in idiopathic pulmonary fibrosis.
- Idiopathic nonspecific Interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?
- Clinical and genetic risk factors for pneumonia in systemic lupus erythematosus.
- Idiopathic Interstitial pneumonia: do community and academic physicians agree on diagnosis?
- Respiratory bronchiolitis-Interstitial lung disease: long-term outcome.
- Clinical problem-solving. Anchors away.
- Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern.
- Anticoagulant therapy and idiopathic pulmonary fibrosis.
- Current perspectives on the treatment of idiopathic pulmonary fibrosis.
- Classification and natural history of the idiopathic Interstitial pneumonias.
- Achieving diversity in academic internal medicine: recommendations for leaders.
- COPD: a dust-induced Disease?
- Clinical advances in the diagnosis and therapy of the Interstitial lung diseases.
- Idiopathic Interstitial pneumonias: CT features.
- Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis.
- Inequality in health care: unjust, inhumane, and unattended!
- Idiopathic Interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?
- Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis.
- The effect of pulmonary fibrosis on survival in patients with hypersensitivity pneumonitis.
- The case for diversity in academic internal medicine.
- Idiopathic Interstitial pneumonias: progress in classification, diagnosis, pathogenesis and management.
- Miscellaneous causes of bronchiolitis: inhalational, infectious, drug-induced, and idiopathic.
- Radiologic findings are strongly associated with a pathologic diagnosis of usual Interstitial pneumonia.
- Sarcoidosis following HIV infection: evidence for CD4+ lymphocyte dependence.
- Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis.
- Demystifying idiopathic Interstitial pneumonia.
- Basic fibroblast growth factor and its receptors in idiopathic pulmonary fibrosis and lymphangioleiomyomatosis.
- Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group.
- Nonspecific Interstitial pneumonia and systemic sclerosis.
- Racial disparities in clinical trials.
- Nonspecific Interstitial pneumonitis as the sole histologic expression of hypersensitivity pneumonitis.
- Safety of pirfenidone in patients with idiopathic pulmonary fibrosis: integrated analysis of cumulative data from 5 clinical trials.
Schools
Harvard Medical School
Grady Emory University Affil Hospital
University Colo Health Science Center
Conditions Treated
- Interstitial Lung Disease
- Sarcoidosis
- Sleep Apnea
Doctors Specialties
- Pulmonology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Elected Member
- Whos Who in Medicine and Healthcare
Education
-
University of Colorado -
Harvard Medical School
Hospital
-
San Francisco General Hospital and Trauma Center -
UCSF Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. David M. Claman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carolyn S. Calfee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adithya Cattamanchi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Oscar A. Estrada, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John R. Greenland, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald L. McDonald, MD |
|
|
Dr. Nadia K. Tchao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aparna B. Sundaram, MD
This Doctor is OpenDoctor Recommended.
|